Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery

PHASE4CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
Open Angle Glaucoma
Interventions
DEVICE

Collagen Matrix in Glaucoma Filtering Surgery

Collagen Matrix implantation in Glaucoma Filtering Surgery

DRUG

Mitomycin-C(MMC) and glaucoma filtering surgery

If mitomycin -C is applied, a single cellulose sponge soaked with Mitomycin-C(MMC) (0.2mg/ml - 0.4mg/ml) is fashioned into an approximate 2.0 × 4.0 mm rectangular shape and applied to the scleral bed and subconjunctival space taking care to avoid exposure to the conjunctival wound edge. Application time is 2 minutes for MMC. Then, the area treated is copiously irrigated with balanced salt solution. After operation, appropriate anti-inflammatory and antibiotic eye-drops will be prescribed.

Trial Locations (1)

50931

Hospital of Universität Köln, Cologne

All Listed Sponsors
lead

Pro Top & Mediking Company Limited

INDUSTRY

NCT00538590 - Ologen Collagen Matrix Safety and Effective Comparison With Mitomycin-C(MMC) in Glaucoma Surgery | Biotech Hunter | Biotech Hunter